Trial intelligence / Profile preview

Topical lignocaine versus saline for respiratory complications during pediatric laryngotracheobronchoscopy

ACTRN12610000235000Phase 4Terminated

Sponsor
Prof Britta Regli-von Ungern-Sternberg
Start
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial comparing Topical lignocaine with Saline placebo (2 arms). Primary endpoint: Total respiratory complications intraoperatively and postoperatively. Started Nov 2009; status: terminated.

02

Drugs

lidocaine

Beyond the preview

Go deeper on ACTRN12610000235000.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12610000235000.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call